Loose Regulatory Standards Portend a New Era of Imprecision Oncology

precision oncology, TMB-high, homologous recombination deficiency, Olaparib, pembrolizumab

Precision oncology aims to tailor cancer treatment based on genetic understanding, revolutionizing oncology. The FDA has been approving drugs under precision oncology with broad indications that may not align with studied populations. Examples include the approval of pembrolizumab for a wide ran…

Dec 1^st • 4 mins read